AORT - SEC Form 4 insider transactions

VP, Chief Accounting Officer Horton Amy sold $34,036 worth of shares (901 units at $37.78) and was granted 7,475 shares, increasing direct ownership by 5% to 139,088 units (SEC Form 4)

SVP, General Counsel Holloway Jean F was granted 27,795 shares and sold $485,728 worth of shares (12,805 units at $37.93), increasing direct ownership by 9% to 185,095 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. was granted 21,838 shares and sold $81,180 worth of shares (2,149 units at $37.78), increasing direct ownership by 49% to 60,097 units (SEC Form 4)

Chief Commercial Officer Davis John E was granted 28,845 shares and sold $172,748 worth of shares (4,573 units at $37.78), increasing direct ownership by 12% to 230,794 units (SEC Form 4)

EVP, COO, CFO & Treasurer Berry Lance A was granted 40,874 shares and sold $238,591 worth of shares (6,316 units at $37.78), increasing direct ownership by 20% to 210,827 units (SEC Form 4)

President & CEO Mackin James P was granted 116,948 shares and sold $675,692 worth of shares (17,887 units at $37.78), increasing direct ownership by 12% to 947,275 units (SEC Form 4)

VP, Chief Accounting Officer Horton Amy sold $24,374 worth of shares (641 units at $38.02), decreasing direct ownership by 0.48% to 132,514 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. sold $57,532 worth of shares (1,513 units at $38.02), decreasing direct ownership by 4% to 40,408 units (SEC Form 4)

President & CEO Mackin James P sold $566,989 worth of shares (14,911 units at $38.02), decreasing direct ownership by 2% to 848,214 units (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $83,008 worth of shares (2,183 units at $38.02), decreasing direct ownership by 1% to 170,105 units (SEC Form 4)

EVP, COO, CFO & Treasurer Berry Lance A sold $196,893 worth of shares (5,178 units at $38.02), decreasing direct ownership by 3% to 176,269 units (SEC Form 4)

Chief Commercial Officer Davis John E sold $105,861 worth of shares (2,784 units at $38.02), decreasing direct ownership by 1% to 206,522 units (SEC Form 4)

VP, Chief Accounting Officer Horton Amy sold $94,690 worth of shares (2,561 units at $36.97) and was granted 5,658 shares, increasing direct ownership by 2% to 133,155 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. sold $136,013 worth of shares (3,682 units at $36.94), decreasing direct ownership by 8% to 41,921 units (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $175,269 worth of shares (4,747 units at $36.92) and was granted 20,085 shares, increasing direct ownership by 10% to 172,288 units (SEC Form 4)

President & CEO Mackin James P sold $1,285,337 worth of shares (34,898 units at $36.83) and was granted 97,030 shares, increasing direct ownership by 8% to 863,125 units (SEC Form 4)

EVP, COO, CFO & Treasurer Berry Lance A was granted 37,482 shares and sold $347,309 worth of shares (9,466 units at $36.69), increasing direct ownership by 18% to 181,447 units (SEC Form 4)

Chief Commercial Officer Davis John E sold $215,882 worth of shares (5,848 units at $36.92) and was granted 20,438 shares, increasing direct ownership by 7% to 209,306 units (SEC Form 4)

Chief Commercial Officer Davis John E sold $225,550 worth of shares (5,000 units at $45.11), decreasing direct ownership by 3% to 193,842 units (SEC Form 4)

VP, Chief Accounting Officer Horton Amy sold $203,084 worth of shares (4,572 units at $44.42), decreasing direct ownership by 3% to 130,058 units (SEC Form 4)

President & CEO Mackin James P exercised 30,921 shares at a strike of $29.62 and sold $1,405,700 worth of shares (30,921 units at $45.46) (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $331,370 worth of shares (7,315 units at $45.30), decreasing direct ownership by 4% to 156,093 units (SEC Form 4)

President & CEO Mackin James P exercised 30,921 shares at a strike of $29.62 and sold $1,408,730 worth of shares (30,921 units at $45.56) (SEC Form 4)

VP, Chief Accounting Officer Horton Amy gifted 750 shares, decreasing direct ownership by 0.55% to 134,630 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. exercised 47,376 shares at a strike of $14.21 and sold $2,133,920 worth of shares (47,376 units at $45.04) (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. exercised 3,388 shares at a strike of $15.48 and sold $674,825 worth of shares (15,276 units at $44.18), decreasing direct ownership by 21% to 44,753 units (SEC Form 4)

Director Hoff Elizabeth A sold $189,412 worth of shares (4,200 units at $45.10), decreasing direct ownership by 13% to 27,189 units (SEC Form 4)

SVP, General Counsel Holloway Jean F exercised 12,787 shares at a strike of $29.62 and sold $576,502 worth of shares (12,787 units at $45.09) (SEC Form 4)

Chief Commercial Officer Davis John E exercised 12,787 shares at a strike of $29.62 and sold $574,392 worth of shares (12,787 units at $44.92) (SEC Form 4)

VP, Chief Accounting Officer Horton Amy sold $274,380 worth of shares (6,000 units at $45.73), decreasing direct ownership by 4% to 135,380 units (SEC Form 4)

VP, Chief Accounting Officer Horton Amy sold $159,678 worth of shares (3,482 units at $45.86), decreasing direct ownership by 2% to 141,380 units (SEC Form 4)

Chief Commercial Officer Davis John E sold $300,966 worth of shares (6,563 units at $45.86), decreasing direct ownership by 3% to 198,842 units (SEC Form 4)

President & CEO Mackin James P sold $1,568,802 worth of shares (34,210 units at $45.86), decreasing direct ownership by 4% to 800,993 units (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $264,188 worth of shares (5,761 units at $45.86), decreasing direct ownership by 3% to 163,408 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. sold $228,969 worth of shares (4,993 units at $45.86), decreasing direct ownership by 8% to 56,641 units (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $593,872 worth of shares (12,960 units at $45.82) and exercised 10,000 shares at a strike of $11.03, decreasing direct ownership by 2% to 169,169 units (SEC Form 4)

President & CEO Mackin James P sold $784,402 worth of shares (17,580 units at $44.62), decreasing direct ownership by 2% to 835,203 units (SEC Form 4)

Chief Commercial Officer Davis John E sold $150,500 worth of shares (3,373 units at $44.62), decreasing direct ownership by 2% to 205,405 units (SEC Form 4)

VP, Chief Accounting Officer Horton Amy sold $79,823 worth of shares (1,789 units at $44.62), decreasing direct ownership by 1% to 144,862 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. sold $114,492 worth of shares (2,566 units at $44.62), decreasing direct ownership by 4% to 61,634 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. exercised 18,200 shares at a strike of $11.03 and sold $801,219 worth of shares (18,200 units at $44.02) (SEC Form 4)

SVP, General Counsel Holloway Jean F exercised 10,000 shares at a strike of $11.03 and sold $443,700 worth of shares (10,000 units at $44.37) (SEC Form 4)

President & CEO Mackin James P sold $528,988 worth of shares (12,500 units at $42.32), decreasing direct ownership by 1% to 852,783 units (SEC Form 4)

SVP, General Counsel Holloway Jean F exercised 16,975 shares at a strike of $26.24 and sold $1,004,610 worth of shares (23,356 units at $43.01), decreasing direct ownership by 4% to 172,129 units (SEC Form 4)

Chief Commercial Officer Davis John E exercised 10,802 shares at a strike of $26.24 and sold $471,756 worth of shares (10,802 units at $43.67) (SEC Form 4)

VP, Chief Accounting Officer Horton Amy exercised 7,992 shares at a strike of $29.62 and sold $307,612 worth of shares (7,992 units at $38.49) (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. sold $442,500 worth of shares (15,000 units at $29.50), decreasing direct ownership by 19% to 64,200 units (SEC Form 4)

SVP, Clinical & MD Affair Stanton Marshall S. sold $743,131 worth of shares (26,132 units at $28.44), decreasing direct ownership by 25% to 79,200 units (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $253,692 worth of shares (8,748 units at $29.00), decreasing direct ownership by 5% to 178,510 units (SEC Form 4)

Amendment: Director Semedo Anthony B. sold $74,027 worth of shares (2,600 units at $28.47), decreasing direct ownership by 6% to 39,384 units (SEC Form 4)

Director Semedo Anthony B. was granted 6,325 shares, increasing direct ownership by 18% to 41,984 units (SEC Form 4)

Director Borgstrom Marna P was granted 6,325 shares, increasing direct ownership by 15% to 49,088 units (SEC Form 4)

Director Bevevino Daniel J was granted 6,325 shares, increasing direct ownership by 4% to 150,061 units (SEC Form 4)

Director Ackerman Thomas F was granted 6,325 shares, increasing direct ownership by 4% to 149,896 units (SEC Form 4)

Director Salveson Jon W was granted 6,325 shares, increasing direct ownership by 5% to 129,840 units (SEC Form 4)

Director Hoff Elizabeth A was granted 6,325 shares, increasing direct ownership by 25% to 31,389 units (SEC Form 4)

Director Burbank Jeffrey H was granted 6,325 shares, increasing direct ownership by 13% to 53,796 units (SEC Form 4)

Director Bullock James was granted 6,325 shares, increasing direct ownership by 10% to 68,647 units (SEC Form 4)

Director Semedo Anthony B. sold $74,027 worth of shares (2,600 units at $28.47), decreasing direct ownership by 7% to 33,059 units (SEC Form 4)

SVP, General Counsel Holloway Jean F sold $287,854 worth of shares (9,926 units at $29.00), decreasing direct ownership by 5% to 187,258 units (SEC Form 4)